BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 27671043)

  • 1. [Clinical study of high intensity focused ultrasound ablation combined with GnRH-a and LNG-IUS for the treatment of adenomyosis].
    Ye MZ; Deng XL; Zhu XG; Xue M
    Zhonghua Fu Chan Ke Za Zhi; 2016 Sep; 51(9):643-649. PubMed ID: 27671043
    [No Abstract]   [Full Text] [Related]  

  • 2. High-Intensity Focused Ultrasound Combined With Gonadotropin-Releasing Hormone Agonist or Levonorgestrel-Releasing Intrauterine System in Treating Dysmenorrhea of Severe Adenomyosis.
    Xu Y; Zhou Z; Wang H; Shao L; Liu G
    J Comput Assist Tomogr; 2021 Mar-Apr 01; 45(2):224-231. PubMed ID: 33661158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of high-intensity focused ultrasound ablation combined with mifepristone and levonorgestrel-releasing intrauterine system to treat symptomatic adenomyosis.
    Zhu H; Ma Q; Dong G; Yang L; Li Y; Song S; Mu Y
    Int J Hyperthermia; 2023; 40(1):2161641. PubMed ID: 36586419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of HIFU combined with GnRH-a and LNG-IUS for adenomyosis patients who failed to respond to drug therapies: two-year follow-up results.
    Peng Y; Dai Y; Yu G; Yang X; Wen C; Jin P
    Int J Hyperthermia; 2021; 38(1):1271-1275. PubMed ID: 34423729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the treatment efficacies of HIFU, HIFU combined with GnRH-a, and HIFU combined with GnRH-a and LNG-IUS for adenomyosis: A systematic review and meta-analysis.
    Otgontuya A; Jeng CJ; Wu TN; Chuang LT; Shen J
    Taiwan J Obstet Gynecol; 2023 Mar; 62(2):226-238. PubMed ID: 36965889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-intensity focused ultrasound (HIFU) combined with gonadotropin-releasing hormone analogs (GnRHa) and levonorgestrel-releasing intrauterine system (LNG-IUS) for adenomyosis: a case series with long-term follow up.
    Haiyan S; Lin W; Shuhua H; Wang W
    Int J Hyperthermia; 2019; 36(1):1179-1185. PubMed ID: 31793356
    [No Abstract]   [Full Text] [Related]  

  • 7. High intensity focused ultrasound treatment of adenomyosis: a comparative study.
    Guo Q; Xu F; Ding Z; Li P; Wang X; Gao B
    Int J Hyperthermia; 2018; 35(1):505-509. PubMed ID: 30306813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of high-intensity focused ultrasound combined with LNG-IUS for adenomyosis: a systematic review and meta-analysis.
    Zhao TT; Pang LL; Yang LL; Li RN; Fan LX; Wen Y
    Arch Gynecol Obstet; 2023 Aug; 308(2):351-362. PubMed ID: 35947146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotrophin-releasing hormone agonist combined with high-intensity focused ultrasound ablation for adenomyosis: a clinical study.
    Guo Y; Duan H; Cheng J; Zhang Y
    BJOG; 2017 Aug; 124 Suppl 3():7-11. PubMed ID: 28856862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined therapeutic effects of HIFU, GnRH-a and LNG-IUS for the treatment of severe adenomyosis.
    Yang X; Zhang X; Lin B; Feng X; Aili A
    Int J Hyperthermia; 2019; 36(1):486-492. PubMed ID: 30994010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of High-Intensity Focused Ultrasound Combined With GnRH-a for Adenomyosis: A Systematic Review and Meta-Analysis.
    Pang LL; Mei J; Fan LX; Zhao TT; Li RN; Wen Y
    Front Public Health; 2021; 9():688264. PubMed ID: 34485218
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term efficacy and safety of levonorgestrel releasing intrauterine system in the treatment of adenomyosis: evidence mapping.
    Shi J; Gu Z; Wu Y; Li X; Zhang J; Zhang C; Yan H; Dai Y; Leng J
    Arch Gynecol Obstet; 2024 Jul; 310(1):55-67. PubMed ID: 38836931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A prospective cohort study on effects of levonorgestrel-releasing intrauterine system for adenomyosis with severe dysmenorrhea].
    Li L; Leng JH; Dai Y; Zhang JJ; Jia SZ; Li XY; Shi JH; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):345-51. PubMed ID: 27256441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis.
    Park DS; Kim ML; Song T; Yun BS; Kim MK; Jun HS; Seong SJ
    Taiwan J Obstet Gynecol; 2015 Aug; 54(4):412-5. PubMed ID: 26384061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of medical treatment for adenomyosis after adenomyomectomy.
    Li Q; Yuan M; Li N; Zhen Q; Chen C; Wang G
    J Obstet Gynaecol Res; 2020 Oct; 46(10):2092-2099. PubMed ID: 32725682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
    Sheng J; Zhang WY; Zhang JP; Lu D
    Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of high-intensity focused ultrasound combined with levonorgestrel-releasing intrauterine system on patients with adenomyosis.
    Cai Y; Sun Y; Xu F; Wu Y; Ren C; Hao X; Gao B; Cao Q
    Sci Rep; 2023 Jun; 13(1):9903. PubMed ID: 37336924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment with Levonorgestrel Releasing Intrauterine System (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomimyois: clinical and ultrasonographic reports.
    Costanzi F; De Marco MP; Colombrino C; Ciancia M; Torcia F; Ruscito I; Bellati F; Frega A; Cozza G; Caserta D
    Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3432-3439. PubMed ID: 34002816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of related factors influencing postoperative recurrence of adenomyosis treated with HIFU.
    Fan LX; Zhang Y; Yang LL; Ji XL; Wang Y; Huang YF; Shi L; Wen Y
    Arch Gynecol Obstet; 2024 May; 309(5):1765-1773. PubMed ID: 38347252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pre-treatment with gonadotropin-releasing hormone analogue GnRH-α on high-intensity focussed ultrasound ablation for diffuse adenomyosis: a preliminary study.
    Xiao-Ying Z; Ying-Shu G; Jiu-Mei C; Jin-Juan W; Hong Y; Chun-Yi Z; Hua D
    Int J Hyperthermia; 2018 Dec; 34(8):1289-1297. PubMed ID: 29447020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.